Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.415 USD | +1.07% | +9.30% | -28.43% |
05-13 | Ikena Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-12 | Ikena Oncology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.43% | 67.56M | |
+33.02% | 50.85B | |
+0.29% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+10.73% | 26.11B | |
-22.15% | 19.13B | |
+8.57% | 13.05B | |
+27.11% | 12.16B | |
+24.43% | 12.08B |
- Stock Market
- Equities
- IKNA Stock
- News Ikena Oncology, Inc.
- Ikena Oncology Completes Acquisition of Pionyr Immunotherapeutics in All-Stock Deal